Shield Therapeutics swings to losses in first half
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year.
Read moreMon, 27th Sep 2021 14:26
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year.
Read moreAIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal
Read moreShield Therapeutics shares fall as swings to loss in first half
Read moreTRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Korea.
Read moreTRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
Read moreTRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
Read moreEXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise
Read more(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Friday that Greg Madison has been appointed as its chief executive officer, with effect from 1 June.
Read moreIN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange
Read moreTRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy
Read moreTRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls
Read moreTRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million
Read more